About Biodesix
Biodesix is a company based in Boulder (United States) founded in 2005.. Biodesix has raised $200.16 million across 25 funding rounds from investors including Lincoln Park Capital. The company has 273 employees as of December 31, 2024. Biodesix has completed 2 acquisitions, including IndiDX and Xpresys Lung. Biodesix offers products and services including Diagnostic Tests and Development Services. Biodesix operates in a competitive market with competitors including Oncimmune, OncoCyte, Broncus, Riverain Tech and ONCOHOST, among others.
- Headquarter Boulder, United States
- Employees 273 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biodesix, Inc.
-
Annual Revenue
$71.32 M45.3as on Dec 31, 2024
-
Net Profit
$-42.93 M17.67as on Dec 31, 2024
-
EBITDA
$-28.8 M19.52as on Dec 31, 2024
-
Total Equity Funding
$200.16 M (USD)
in 25 rounds
-
Latest Funding Round
$40.3 M (USD), Post-IPO
Nov 23, 2022
- Investors
-
Employee Count
273
as on Dec 31, 2024
-
Investments & Acquisitions
IndiDX
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biodesix
Biodesix is a publicly listed company on the NASDAQ with ticker symbol BDSX in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biodesix
Biodesix offers a comprehensive portfolio of products and services, including Diagnostic Tests and Development Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tests for lung cancer detection and personalized treatment guidance
Custom services for diagnostic tools and therapeutics development
Unlock access to complete
Unlock access to complete
Leadership Team
21 people
Software Development Team
11 people
Operations Team
6 people
Sales and Marketing
4 people
Business Team
3 people
Product Management Team
2 people
Human Resources and Administration
2 people
Customer Team
2 people
Unlock access to complete
Funding Insights of Biodesix
Biodesix has successfully raised a total of $200.16M across 25 strategic funding rounds. The most recent funding activity was a Post-IPO round of $40.3 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 25
- Last Round Post-IPO — $40.3M
-
First Round
First Round
(28 Sep 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Post-IPO - Biodesix | Valuation |
investors |
|
| Apr, 2022 | Amount | Post-IPO - Biodesix | Valuation |
investors |
|
| Mar, 2022 | Amount | Post-IPO - Biodesix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biodesix
Biodesix has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lincoln Park Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward North American opportunities.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biodesix
Biodesix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include IndiDX and Xpresys Lung. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Proteomics-based liquid biopsy for lung cancer is provided.
|
2013 | ||||
|
Blood-based diagnostics for oncology.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biodesix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biodesix Comparisons
Competitors of Biodesix
Biodesix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oncimmune, OncoCyte, Broncus, Riverain Tech and ONCOHOST, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostics and risk assessment solutions for lung cancer are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive technologies for lung disease treatment are developed.
|
|
| domain | founded_year | HQ Location |
Software tools are developed for early lung disease detection.
|
|
| domain | founded_year | HQ Location |
AI-based proteomic analysis for oncology therapy planning is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biodesix
Frequently Asked Questions about Biodesix
When was Biodesix founded?
Biodesix was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Where is Biodesix located?
Biodesix is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Who is the current CEO of Biodesix?
Scott Hutton is the current CEO of Biodesix.
Is Biodesix a funded company?
Biodesix is a funded company, having raised a total of $200.16M across 25 funding rounds to date.
How many employees does Biodesix have?
As of Dec 31, 2024, the latest employee count at Biodesix is 273.
What is the annual revenue of Biodesix?
Annual revenue of Biodesix is $71.32M as on Dec 31, 2024.
What does Biodesix do?
Biodesix was founded in 2005 and is headquartered in Boulder, United States. Diagnostic assays for cancer detection are developed by the company within the healthcare sector. In vitro diagnostic tests are provided, including Nodify Lung, which features two blood-based proteomic tests for assessing malignancy risk in lung nodules, and GeneStrat NGS for broad tumor mutation analysis. Operations focus on advancing precision medicine tools.
Who are the top competitors of Biodesix?
What products or services does Biodesix offer?
Biodesix offers Diagnostic Tests and Development Services.
Is Biodesix publicly traded?
Yes, Biodesix is publicly traded on NASDAQ under the ticker symbol BDSX.
How many acquisitions has Biodesix made?
Biodesix has made 2 acquisitions, including IndiDX, and Xpresys Lung.
Who are Biodesix's investors?
Biodesix has 1 investor. Key investors include Lincoln Park Capital.
What is Biodesix's ticker symbol?
The ticker symbol of Biodesix is BDSX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.